Revenue: The sum of all revenue fields included for a company's operating activities.
Omega Therapeutics, Inc. (OMGAQ) had Revenue of $2.61M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
|
Revenue |
$2.61M |
$-16.44M |
|
-- |
|
$2.61M |
|
$19.03M |
|
$-16.42M |
|
$-0.02M |
|
$-16.44M |
|
$-16.44M |
|
$-16.44M |
|
$-16.44M |
|
$-16.44M |
|
$-16.44M |
|
$-16.42M |
|
$-13.31M |
|
55.16M |
|
55.16M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$38.95M |
|
$4.50M |
|
$113.77M |
|
$152.73M |
|
$24.17M |
|
$11.59M |
|
$117.01M |
|
$141.18M |
|
$11.54M |
|
$11.54M |
|
$11.54M |
|
55.46M |
|
| Cash Flow Statement Financials | |
$-38.49M |
|
$4.05M |
|
$-3.63M |
|
$68.78M |
|
$30.72M |
|
$-38.07M |
|
$6.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.61 |
|
-- |
|
-- |
|
0.50 |
|
1.35 |
|
100.00% |
|
-628.64% |
|
-628.64% |
|
-- |
|
-629.56% |
|
-629.56% |
|
$-39.44M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
5.37 |
|
16.75 |
|
-142.46% |
|
-142.46% |
|
-10.77% |
|
-71.09% |
|
$0.21 |
|
$-0.71 |
|
$-0.70 |
|